Clara Lemos

972 total citations
24 papers, 693 citations indexed

About

Clara Lemos is a scholar working on Molecular Biology, Oncology and Rheumatology. According to data from OpenAlex, Clara Lemos has authored 24 papers receiving a total of 693 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Oncology and 6 papers in Rheumatology. Recurrent topics in Clara Lemos's work include Folate and B Vitamins Research (6 papers), Colorectal Cancer Treatments and Studies (4 papers) and Cancer Mechanisms and Therapy (3 papers). Clara Lemos is often cited by papers focused on Folate and B Vitamins Research (6 papers), Colorectal Cancer Treatments and Studies (4 papers) and Cancer Mechanisms and Therapy (3 papers). Clara Lemos collaborates with scholars based in Germany, Portugal and United States. Clara Lemos's co-authors include Fátima Martel, Rosário Monteiro, Elisa Keating, Godefridus J. Peters, Ulrike Stein, Romano Danesi, Elisa Giovannetti, Giuseppe Giaccone, Ulrike Sack and Kees Smid and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Clara Lemos

24 papers receiving 688 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Clara Lemos Germany 16 315 260 189 85 58 24 693
Kwi Hye Koh United States 16 320 1.0× 253 1.0× 54 0.3× 137 1.6× 63 1.1× 21 810
Kristin Werner Germany 13 270 0.9× 283 1.1× 69 0.4× 136 1.6× 106 1.8× 22 755
Yukimoto Ishii Japan 18 470 1.5× 193 0.7× 105 0.6× 103 1.2× 219 3.8× 57 971
Jong‐Shiaw Jin Taiwan 18 379 1.2× 191 0.7× 96 0.5× 124 1.5× 99 1.7× 51 900
Ali N. Chamseddine France 12 287 0.9× 246 0.9× 111 0.6× 98 1.2× 47 0.8× 27 742
P. Kölle Germany 9 557 1.8× 102 0.4× 299 1.6× 237 2.8× 56 1.0× 14 925
Ning Zhu China 19 340 1.1× 187 0.7× 171 0.9× 109 1.3× 73 1.3× 61 817
Tamás Csonka Hungary 9 525 1.7× 207 0.8× 92 0.5× 71 0.8× 73 1.3× 22 793

Countries citing papers authored by Clara Lemos

Since Specialization
Citations

This map shows the geographic impact of Clara Lemos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clara Lemos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clara Lemos more than expected).

Fields of papers citing papers by Clara Lemos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clara Lemos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clara Lemos. The network helps show where Clara Lemos may publish in the future.

Co-authorship network of co-authors of Clara Lemos

This figure shows the co-authorship network connecting the top 25 collaborators of Clara Lemos. A scholar is included among the top collaborators of Clara Lemos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clara Lemos. Clara Lemos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
O’Donovan, Daniel H., et al.. (2023). Addressing the Reciprocal Crosstalk between the AR and the PI3K/AKT/mTOR Signaling Pathways for Prostate Cancer Treatment. International Journal of Molecular Sciences. 24(3). 2289–2289. 32 indexed citations
2.
Hillig, R.C., Katja Zimmermann, Stefan Kaulfuß, et al.. (2022). BAY-069, a Novel (Trifluoromethyl)pyrimidinedione-Based BCAT1/2 Inhibitor and Chemical Probe. Journal of Medicinal Chemistry. 65(21). 14366–14390. 14 indexed citations
3.
Lemos, Clara, Volker Schulze, Simon J. Baumgart, et al.. (2021). The potent AMPK inhibitor BAY-3827 shows strong efficacy in androgen-dependent prostate cancer models. Cellular Oncology. 44(3). 581–594. 29 indexed citations
5.
Lemos, Clara, Duy Nguyen, Lars Wortmann, et al.. (2018). Abstract 5866: Discovery and profiling of a highly potent and selective ERK5 inhibitor: BAY-885. Cancer Research. 78(13_Supplement). 5866–5866. 1 indexed citations
6.
Lemos, Clara, Volker Schulze, Benjamin Bader, et al.. (2018). Abstract 5873: BAY-3827, a selective inhibitor of AMPK for the evaluation of the role of AMPK in Myc-dependent tumors. Cancer Research. 78(13_Supplement). 5873–5873. 1 indexed citations
7.
Lemos, Clara, Markus Hardt, Manisha Juneja, et al.. (2016). MACC1 Induces Tumor Progression in Transgenic Mice and Colorectal Cancer Patients via Increased Pluripotency Markers Nanog and Oct4. Clinical Cancer Research. 22(11). 2812–2824. 43 indexed citations
8.
Lemos, Clara, Markus Hardt, Manisha Juneja, et al.. (2016). Abstract 2689: First MACC1 transgenic mice demonstrate tumor progression via the newly discovered MACC1/Nanog/Oct4 axis. Cancer Research. 76(14_Supplement). 2689–2689. 1 indexed citations
9.
Lemos, Clara, Ana Faria, Manuela Meireles, et al.. (2012). Thiamine is a substrate of organic cation transporters in Caco-2 cells. European Journal of Pharmacology. 682(1-3). 37–42. 27 indexed citations
10.
Lemos, Clara, et al.. (2012). Anti-metastatic Treatment in Colorectal Cancer: Targeting Signaling Pathways. Current Pharmaceutical Design. 19(5). 841–863. 11 indexed citations
11.
Sack, Ulrike, Wolfgang Walther, Dominic A. Scudiero, et al.. (2011). S100A4-induced cell motility and metastasis is restricted by the Wnt/β-catenin pathway inhibitor calcimycin in colon cancer cells. Molecular Biology of the Cell. 22(18). 3344–3354. 98 indexed citations
12.
Lemos, Clara, Elisa Giovannetti, Paolo Andrea Zucali, et al.. (2011). Impact of ABCG2 Polymorphisms on the Clinical Outcome and Toxicity of Gefitinib in Non-Small-Cell Lung Cancer Patients. Pharmacogenomics. 12(2). 159–170. 53 indexed citations
14.
Silva, Patrı́cia, Delminda Neves, Clara Lemos, et al.. (2008). Characterization of rat heart alkaline phosphatase isoenzymes and modulation of activity. Brazilian Journal of Medical and Biological Research. 41(7). 600–609. 17 indexed citations
15.
Keating, Elisa, Pedro Gonçalves, Clara Lemos, et al.. (2007). Progesterone Inhibits Folic Acid Transport in Human Trophoblasts. The Journal of Membrane Biology. 216(2-3). 143–152. 22 indexed citations
16.
Keating, Elisa, Clara Lemos, Pedro Gonçalves, & Fátima Martel. (2007). Acute and chronic effects of some dietary bioactive compounds on folic acid uptake and on the expression of folic acid transporters by the human trophoblast cell line BeWo. The Journal of Nutritional Biochemistry. 19(2). 91–100. 31 indexed citations
17.
Keating, Elisa, Clara Lemos, Isabel Azevedo, & Fátima Martel. (2006). Characteristics of Thiamine Uptake by the BeWo Human Trophoblast Cell Line. BMB Reports. 39(4). 383–393. 16 indexed citations
18.
Keating, Elisa, Clara Lemos, Rosário Monteiro, Isabel Azevedo, & Fátima Martel. (2004). The effect of a series of organic cations upon the plasmalemmal serotonin transporter, SERT. Life Sciences. 76(1). 103–119. 19 indexed citations
19.
Martel, Fátima, Rosário Monteiro, Clara Lemos, & Maria Augusta Vieira‐Coelho. (2004). In vitro and in vivo effect of fluoxetine on the permeability of3H-serotonin across rat intestine. Canadian Journal of Physiology and Pharmacology. 82(11). 940–950. 9 indexed citations
20.
Martel, Fátima, Rosário Monteiro, & Clara Lemos. (2003). Uptake of Serotonin at the Apical and Basolateral Membranes of Human Intestinal Epithelial (Caco-2) Cells Occurs through the Neuronal Serotonin Transporter (SERT). Journal of Pharmacology and Experimental Therapeutics. 306(1). 355–362. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026